Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
Waldencast plc finalized the sale of its Obagi Medical dermatological skincare business to Bridgepoint for up to $460 million. The transaction enables Waldencast to repay all outstanding senior debt and concentrate on expanding its Milk Makeup brand, a clean prestige beauty line. Key executives from Waldencast will transition to lead Obagi Medical …